OLUMIANT -
ATOPIC DERMATITIS
USA CAMPAIGN
Healthcare Professional Responsible (HCP)
Healthcare Professional Responsible (HCP)
Client:
Eli Lilly US
—
GCD: Josh Eastman
CD: Shawn Taylor / Daug Flynn
ACD/Art: Dan Geva - Ekaterina Goldberg
ACD/Copy: Frank Gillam
Copy Supervisor: Eugene Park
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Eli Lilly US
—
GCD: Josh Eastman
CD: Shawn Taylor / Daug Flynn
ACD/Art: Dan Geva - Ekaterina Goldberg
ACD/Copy: Frank Gillam
Copy Supervisor: Eugene Park
Art Director/Graphic Designer: Manuel Benitez
—
Agency:
GREY New York - Toronto
Challenge:
The introduction of a groundbreaking atopic dermatologic treatment in the US pharmaceutical market underscores the significance of actively involving healthcare professionals. This dedication is essential for enhancing patient outcomes and ensuring overall success. Consequently, we have pinpointed key focus areas to craft a meticulously planned advertising campaign targeting healthcare professionals, aiming to raise awareness about the advantages of this innovative medicine.
solution:
A comprehensive strategy was developed, incorporating digital and print tactics targeted at healthcare professionals. The campaign utilized the brand's colours and featured three key figures representing the challenges of Atopic Dermatitis, demonstrating how Olumiant contributes to recovery for an improved quality of life.
Concurrently, the Olumiant website network underwent consistent updates to ensure a user-friendly experience with simplified navigation. The platform now includes vital information such as product awareness, pricing details, usage guidelines, benefits, and potential side effects.
Interactive visual aids (IVAs), web banners, emails, mobile tactics, and printed materials were thoughtfully integrated into the campaign. This multifaceted approach aims to optimize communication and engagement between patients and the brand, to foster brand loyalty, utilize data for future-proofing strategies, and enhance healthcare providers' understanding of the Olumiant treatment.
DERMATOLOGY CONGRESS:
To emphasize the significance and generate awareness about the launch of "Olumiant" for Atopic Dermatitis treatment, we developed a range of graphic materials to assist healthcare representatives in promoting the new medication during the Dermatology Congress for the US market.
Services:
Digital
Social
Retail
Digital
Social
Retail
Photography:
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly
Lightfarm Studios
—
Industry:
Pharmaceuticals, Eli Lilly
